Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast to 2027

 The prevalence of chronic pain imposes a significant health and economic burden due to reduced productivity and treatment expenses. Non-steroidal anti-inflammatory drugs (NSAIDs) are the primary choice for alleviating pain and inflammation. The increasing incidence of conditions like rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, and migraines is driving the demand for these medications. They have become the most widely prescribed drugs worldwide, with approximately 84 million NSAID prescriptions issued annually in the U.S., as stated in a press release by Endo International plc.

Here are some key points about the NSAIDs market as of 2021:

  1. Market Size and Growth: The global NSAIDs market was valued in the billions of US dollars. The market was expected to continue growing, driven by factors such as an aging population, an increasing incidence of chronic diseases, and a rising awareness of the benefits of NSAIDs.
  2. Types of NSAIDs: The market includes various types of NSAIDs, such as ibuprofen, naproxen, aspirin, diclofenac, and others. Each type has specific indications and varying levels of market share.
  3. Indications: NSAIDs are used primarily to manage pain, inflammation, and fever. They find applications in various medical conditions like arthritis, headaches, menstrual cramps, and musculoskeletal injuries.
  4. Prescription vs. Over-the-Counter (OTC): Some NSAIDs are available over-the-counter, while others require a prescription. OTC NSAIDs are widely used for mild to moderate pain relief, while prescription NSAIDs are often used for more severe conditions.
  5. Distribution Channels: NSAIDs are distributed through various channels, including hospitals, pharmacies, online retail, and others. The choice of channel depends on factors like the type of NSAID, the severity of the condition, and regional preferences.
  6. Regional Trends: The market for NSAIDs may vary significantly by region. Factors such as healthcare infrastructure, regulatory policies, and cultural preferences can influence market dynamics.
  7. Competitive Landscape: The NSAIDs industry is competitive, with several pharmaceutical companies manufacturing and marketing these drugs. Some of the major players in the market include Pfizer, Bayer, Novartis, Johnson & Johnson, and GlaxoSmithKline, among others.

Comments

Post a Comment

Popular posts from this blog

Autoinjectors Industry Size 2024-2030

  The global " Autoinjectors Market Size 2024 ” Forecast to 2030 research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The Autoinjectors Market report also examines the current state of the industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial data. Get a sample PDF of the report at -  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/108507 The global autoinjectors market size was USD 102.51 billion in 2022. The market is projected to grow from USD 111.16 billion in 2023 to USD 233.69 billion by 2030, exhibiting a CAGR of 11.2% during the forecast period. Autoinjectors Market Competitive Analysis: The Autoinjectors Market report examines competitive sc...
Read more

Veterinary Diagnostics Market Growth in United States

  The global veterinary diagnostics market size is projected to reach USD 9.5 billion by 2026, exhibiting a CAGR of 10.0% during the forecast period. Rising prevalence of zoonotic diseases such as swine flu and rabies is the main factor driving the growth of this market. Zoonotic diseases are those which humans contract from animals, birds or insects. They pose grave danger not only to the person infected, but also to other people who might come in close contact with him or her, laying the groundwork for an epidemic. A study published by the Centers for Disease Control and Prevention (CDC) states that 75% of emerging infectious diseases affecting humans are zoonotic in origin. This was already witnessed during the recent Ebola outbreak and rapid spread of swine flu a few years earlier. Preventing the birth of such diseases is crucial for public health as they also cause huge economic losses. According to the WHO, zoonotic epidemics between 1997 and 2009 led to a loss of about USD 8...
Read more

Inflammatory Bowel Disease Treatment Industry Is Booming Worldwide by 2030

 The " Inflammatory Bowel Disease Treatment Market  Size 2024” forecasted to 2030 research provides accurate economic, global, and country-level predictions and analyses. It offers a comprehensive perspective on the competitive market landscape, along with an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. Additionally, the Inflammatory Bowel Disease Treatment Market report examines the current state of the industry, predicted future growth, technological advancements, investment prospects, market economics, and financial data. Competitive Analysis: The Inflammatory Bowel Disease Treatment Market report scrutinizes the competitive scenario by analyzing key players in the market. It includes company profiling of leading market players with Porter's five forces analysis and Value Chain analysis. Furthermore, the report discusses strategies employed by companies for expanding their business through mergers, acquisitions, and...
Read more